Acne Is Not a Skin Problem. It Is an Inflammatory, Hormonal, and Gut-Microbiome Problem.

What Is Chronic and Hormonal Acne?

Acne vulgaris is almost always approached as a local skin issue when its biology is systemic. Three mechanisms drive most persistent acne, and they work together in ways that mean addressing only one produces incomplete results.

NF-kB-driven inflammation activates sebaceous glands directly. Elevated IL-1b and TNF-a, the same inflammatory cytokines driving systemic disease, express through the skin by triggering sebum overproduction and follicular inflammation. Androgen and insulin dysregulation amplifies this: androgens drive sebum production, and elevated insulin and IGF-1 from high-glycemic diets amplify androgen signaling in sebaceous tissue. This is the mechanism behind the clinical observation that sugar worsens acne and that improving insulin sensitivity consistently improves skin. Gut dysbiosis is the third driver, allowing inflammatory signals to reach sebaceous glands through systemic circulation. The gut-skin axis is well established, and probiotics and gut repair directly improve acne outcomes in published clinical evidence.

The result is a condition that lives in the skin but is driven by the gut, the endocrine system, and the immune system simultaneously.

Who the Acne Protocol Is For

This protocol is built for patients who are dealing with one or more of the following:

• Persistent inflammatory or cystic acne that has not fully resolved with topicals, antibiotics, or dietary changes
• Hormonal acne that tracks with the menstrual cycle, worsening premenstrually or at ovulation
• Acne alongside insulin resistance, PCOS features, or a history of high-glycemic eating
• Post-antibiotic acne where gut dysbiosis is likely a contributing driver

How the Acne Protocol Works

The baseline panel for this protocol includes fasting insulin, IGF-1, sex hormone panel, inflammatory markers, Vitamin D, and where indicated, a gut assessment. The protocol moves through three stages targeting the inflammation, insulin environment, and gut-skin axis simultaneously.

What the Protocol May Include: berberine for insulin and IGF-1 reduction and gut microbiome reshaping; zinc at therapeutic dose, which has clinical evidence comparable to low-dose antibiotics for P. acnes reduction without microbiome disruption; omega-3 fatty acids for prostaglandin-driven sebaceous inflammation reduction; multi-strain probiotics for the gut-skin axis; and Vitamin D for sebaceous gland regulation. For hormonal acne patterns, DIM to shift estrogen metabolism toward less androgenic pathways, and inositol for patients with PCOS features. As the protocol advances, injectable vitamins at the clinic deliver glutathione for follicular oxidative stress reduction, Vitamin C for collagen synthesis and post-inflammatory hyperpigmentation prevention, B5 for sebum production reduction, and injectable zinc at therapeutic levels. Stage 3 adds peptide therapy including GHK-Cu (copper peptide) for fibroblast activation and post-acne scar repair, BPC-157 for gut barrier repair at the root of the gut-skin axis, and KPV for the TNF-a and IL-6 reduction driving sebaceous gland activation.

Stage 1 (Pathway) addresses the most foundational drivers: insulin, inflammation, and gut repair. Stage 2 (Roadmap) adds injectable delivery at the clinic for therapeutic skin and immune support. Stage 3 (Atlas) is the complete protocol for complex presentations and patients with significant scarring or refractory hormonal acne.